NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Brigham and Women's Rheumatoid Arthritis Sequential Study
Brigham and Women's Rheumatoid Arthritis Sequential Study

NCT01793103

Active Not RecruitingN/A

Sponsor: Brigham and Women's Hospital

Conditions: Rheumatoid Arthritis

Countries: United States

The goal of the present study is to establish a prospective observational cohort of Rheumatoid Arthritis patients in order to 1. Determine and validate biomarkers that predict drug response and toxicity in RA. 2. Determine and validate biomarkers that predict disease activity and prognosis in RA. 3. Evaluate the natural history of treated RA in terms of its clinical, functional and economic outcomes.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

1. Are 18 years of age or older;
2. Are a patient registered at the R.B.Brigham Arthritis Center.
3. Have, at the time of enrollment a diagnosis of RA made by a board certified rheumatologist.
4. Are able and willing to provide informed consent.

Exclusion Criteria:

* less than 18 years of age
* do not have a diagnosis of RA
* have a history of SLE or Psoriasis
Locations (1)
  • Boston, Massachusetts, United States